Galit Zuckerman Stark
Founder, CEO, and board member
Ms. Zuckerman brings to Medasense over fifteen years of entrepreneurship, management and engineering experience in both startups and large corporations. Ms. Zuckerman founded Medasense upon discovering that while advanced algorithms are used frequently in many different industries such as semiconductors, communication, and many others, the discipline of medicine and specifically pain is still left behind.
Before founding Medasense she led a team of algorithm engineers at Applied Materials and worked at Nokia-Siemens and Nice Systems. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.
Ms. Zuckerman holds an M.Sc. degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a B.Sc. in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel-Aviv University, Israel.
CFO, Board Member
Mr. Tabachnik served as the Executive Vice President and Chief Financial Officer of Oridion Systems, a successful patient monitoring company. He led their successful acquisition by the global healthcare company, Covidien, for $346 Million in 2012. Mr. Tabachnik later served as Covidien’s Director of Strategy and Portfolio EMEA. Previously Mr. Tabachnik has held a number of senior accounting positions in various distinguished firms in Israel and South Africa.
Mr. Tabachnik is a Certified Public Accountant in Israel and holds a bachelor’s degree in accounting and economics from the Hebrew University of Jerusalem, Israel.
VP Research and Development
Mr. Costa brings over a decade of experience in algorithm and software development combined with strong practical knowledge of the clinical and regulatory R&D process. As VP R&D for Paieon Medical, a medical device startup in the field of cardiac imaging diagnostics, he led the design and development of their algorithm and software technology, and successfully managed the technical aspects of their clinical and regulatory process. He was previously the Algorithm Group Manager for Applied Materials where he developed several unique Intellectual Property solutions with patents filed and his work published. Prior to this, he has held software engineering roles for Demantra-Oracle and Idioma.
Mr. Costa holds an M.Sc. in Computer Sciences from Bar-Ilan University, Israel.
VP Clinical and Regulatory Affairs
Dr. Harris has previously served in various clinical leadership positions in companies such as Orsan, NanoVibronix, Ultrashape and Mindguard, where he accumulated significant experience in clinical trial management. Prior to joining Medasense, he was the VP Clinical Affairs at Orsan, a brain monitoring device developer, where he managed large scale clinical trials and oversaw their regulatory pathway. His role with NanoVibronix brings direct experience working within the pain sector.
Dr. Harris holds a Ph.D. in Biochemistry and an MBA specializing in Health Administration from the Tel Aviv University, Israel.
VP Business Development & Marketing
Ms. Sofer (EMBA) brings over fifteen years of experience in building commercial and marketing strategy, and developing new business channels. Prior to joining Medasense, Ms. Sofer was the VP Business Development and Marketing at Medisim Ltd., a developer and manufacturer of sophisticated thermometry medical devices. She led the trade and sales activity in the U.S. and Europe and was responsible for the strategic business partnerships. She has also held various business development and marketing leadership positions for Ophir Group and Promarket.
Ms. Sofer served as an outside director of a public company and holds an EMBA from the Recanati Business School –Tel Aviv University